Apogee Enterprises (APOG)
(Delayed Data from NSDQ)
$40.40 USD
-1.59 (-3.79%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $40.37 -0.03 (-0.07%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth D Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
APOG 40.40 -1.59(-3.79%)
Will APOG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APOG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APOG
Wall Street Analysts Think Apogee Enterprises (APOG) Could Surge 25.44%: Read This Before Placing a Bet
Are Investors Undervaluing Apogee Enterprises (APOG) Right Now?
APOG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Apogee Enterprises (APOG) Could Rally 28.24%: Here's is How to Trade
Is Apogee Enterprises (APOG) Stock Undervalued Right Now?
Apogee Beats Q1 Earnings & Revenue Estimates, Hikes FY26 View
Other News for APOG
Dividend Champion, Contender, And Challenger Highlights: Week Of July 27
Reminder - Apogee Enterprises (APOG) Goes Ex-Dividend Soon
Dividend Champion, Contender, And Challenger Highlights: Week Of July 13
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Robinhood To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Tuesday